Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

KINDRED BIOSCIENCES, INC.

(KIN)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť KINDRED BIOSCIENCES, INC.
30/08KINDRED BIOSCIENCES : Market Offering Agreement (Form 8-K)
PU
30/08KINDRED BIOSCIENCES, INC. : Termination of a Material Definitive Agreement, Completion of ..
AQ
26/08KINDRED BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Financial..
AQ
06/08KINDRED BIO : Q2 Earnings Snapshot
AQ
05/08KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
02/08KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/07KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Financial Statemen..
AQ
24/06KINDRED BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Financial..
AQ
22/06KINDRED BIOSCIENCES : Moore Kuehn Encourages KIN, SVOK, ROCR, and DCRC Investors to Contac..
PR
21/06KINDRED BIOSCIENCES INVESTOR ALERT B : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
17/06SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Kindred Biosc..
PR
16/06KINDRED BIOSCIENCES MERGER INVESTIGA : Halper Sadeh LLP Announces Investigation Into Wheth..
BU
16/06KINDRED BIOSCIENCES : FORM OF SUPPORT AGREEMENT (Form 8-K)
PU
16/06KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events, Fina..
AQ
03/06KINDRED BIOSCIENCES : Announces Positive Results from Pivotal Efficacy Study of Parvovirus..
AQ
02/06KINDRED BIOSCIENCES : Announces Positive Results from Pivotal Efficacy Study of Parvovirus..
PU
02/06KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
25/05KINDRED BIOSCIENCES : to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micr..
PR
11/05KINDRED BIO : Q1 Earnings Snapshot
AQ
11/05KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
11/05KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
11/05KINDRED BIOSCIENCES : Announces First Quarter 2021 Financial Results
PR
11/05KINDRED BIOSCIENCES : Announces First Quarter 2021 Financial Results (Form 8-K)
PU
03/05KINDRED BIOSCIENCES : to Announce First Quarter 2021 Financial Results
PR
20/04KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
20/04KINDRED BIOSCIENCES : Unveils Positive Results from its Long-Acting Interleukin-31 Antibod..
PR
16/03KINDRED BIO : Q4 Earnings Snapshot
AQ
16/03KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
16/03KINDRED BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial State..
AQ
25/02KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/02KINDRED BIOSCIENCES : SEC Filing (3/A)
PU
10/02KINDRED BIOSCIENCES : SEC Filing (4/A)
PU
09/02KINDRED BIOSCIENCES, INC. : Change in Directors or Principal Officers, Regulation FD Discl..
AQ
01/02KINDRED BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020KINDRED BIOSCIENCES : Announces Positive Results from Pilot Field Effectiveness Study for ..
AQ
2020KINDRED BIOSCIENCES : Announces Agreement Granting Elanco Exclusive Global Rights for its ..
AQ
2020KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events, Fina..
AQ
2020KINDRED BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
AQ
2020KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KINDRED BIO : 3Q Earnings Snapshot
AQ
2020KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020KINDRED BIOSCIENCES, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
2020KINDRED BIOSCIENCES : to Announce Third Quarter 2020 Financial Results
AQ
2020KINDRED BIOSCIENCES : Announces Expansion of Manufacturing Agreement with Vaxart for COVID..
AQ
2020KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KINDRED BIOSCIENCES : Announces Positive Results from Pivotal Efficacy Study of Parvovirus..
AQ
2020KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KINDRED BIOSCIENCES : to Participate in H.C. Wainwright Global Investment Conference Canto..
AQ
2020KINDRED BIO : 2Q Earnings Snapshot
AQ
2020KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020KINDRED BIOSCIENCES, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
2020KINDRED BIOSCIENCES, INC. : Change in Directors or Principal Officers, Submission of Matte..
AQ
2020KINDRED BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Change in D..
AQ
2020KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Material Modificat..
AQ
2020KINDRED BIO : 1Q Earnings Snapshot
AQ
2020KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020KINDRED BIOSCIENCES, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
2020KINDRED BIOSCIENCES : Announces Completion of Mirataz Transaction
AQ
2020KINDRED BIOSCIENCES, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
2020KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Financial Statemen..
AQ
2020KINDRED BIOSCIENCES : Announces Mirataz Transaction and Reports Fourth Quarter and Full Ye..
AQ
2020KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020KINDRED BIO : 4Q Earnings Snapshot
AQ
2020KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Financial Statemen..
AQ
2020KINDRED BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2019KINDRED BIOSCIENCES : Announces European Commission Approval of Mirataz 20 mg/g Transderma..
AQ
2019KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2019KINDRED BIOSCIENCES : Receives FDA Approval of Zimeta for the Control of Pyrexia in Horses
AQ
2019KINDRED BIOSCIENCES : Announces Positive Results from Pilot Field Effectiveness Study of i..
PU
2014KINDRED BIOSCIENCES : KindredBio Schedules Release of 2014 Second Quarter Financial Result..
PU
2013KIND BIOS : Kindred Bio Announces Pricing of Initial Public Offering
PU
2013KIND BIOS : Kindred Bio Announces Launch of Initial Public Offering
PU
Volgende evenement op KINDRED BIOSCIENCES, INC.
09/11/21